What is Eating Disorders?
Eating disorders are among the most misunderstood, underdiagnosed, and underreported mental health crises in the United States — and in 2026, the data makes clear that this crisis is not shrinking. An estimated 9% of the entire US population will struggle with an eating disorder at some point in their lives, translating to nearly 28.8 million Americans — more people than live in Texas. These are not fringe conditions. They sit alongside opioid addiction as one of the deadliest categories of mental health disorder, with eating disorders now ranked as having the second-highest mortality rate of any mental illness in the country. Yet despite the scale of the problem, the vast majority of those affected — roughly 94% — never receive any formal treatment. The gap between the reality of how many people are affected and how many people are being helped is, in every measurable sense, staggering.
What makes the US eating disorder statistics 2026 particularly sobering is how persistently they defy public perception. Most people picture a teenage girl when they think of an eating disorder. The data tells a far more complex story: 1 in 3 people with an eating disorder is male, eating disorders affect adults well into their 70s and 80s, and they are just as prevalent among Black, Hispanic, and Asian Americans as among white populations — yet those same communities are dramatically less likely to be diagnosed or treated. Meanwhile, the economic toll is concrete and massive: $64.7 billion every single year in financial costs alone, with $48.6 billion of that coming from lost productivity — a burden distributed across individuals, employers, and government systems that are chronically underfunding research and prevention in the very same breath. The CDC, as of 2026, still runs no ongoing national surveillance system specifically tracking eating disorder prevalence — leaving the country flying largely blind on one of its most costly public health problems.
US Eating Disorder Key Facts 2026 | Quick Reference Table
| Fact / Metric | Verified Statistic |
|---|---|
| Lifetime Prevalence — US Population | ~9% — approximately 28.8–31 million Americans will have an eating disorder in their lifetime |
| Active Prevalence (Any Given Year) | 1–3% of the US population is actively struggling at any given time |
| Deaths Per Year (Direct Result) | 10,200 deaths annually — one death every 52 minutes |
| Mortality Ranking Among Mental Illnesses | Second-highest mortality rate of any mental illness — just after opioid addiction |
| Anorexia Nervosa Mortality Rate | 10.4% — highest of any psychiatric disorder; 5.1 deaths per 1,000 person-years (JAMA 2025) |
| Anorexia Nervosa Standardized Mortality Ratio (SMR) | 5.21 — anorexia patients are over 5 times more likely to die than same-age peers without the disorder |
| Anorexia — Deaths From Suicide | 25% of all deaths among anorexia patients are from suicide (JAMA 2025) |
| Bulimia Nervosa Mortality Rate | ~3.9% of individuals die from complications |
| Bulimia Nervosa Standardized Mortality Ratio (SMR) | 2.20 (meta-analysis, ScienceDirect 2025) |
| Binge Eating Disorder (BED) SMR | 1.46 — still elevated vs. general population |
| Overall Eating Disorder SMR (all subtypes combined) | 3.39 — individuals with any eating disorder are over 3 times more likely to die (ScienceDirect meta-analysis, 2025) |
| Emergency Room Positive Screening Rate | 16% of adult ER patients screen positive for an eating disorder |
| Patients Medically Classified as “Underweight” | Fewer than 6% — the majority of eating disorder patients are normal or higher weight |
| People in Larger Bodies With Eating Disorders | Highest BMI correlates with highest lifetime eating disorder risk |
| Annual US Economic Cost | $64.7 billion per year in financial costs (Deloitte Access Economics / Harvard STRIPED) |
| Cost Per Affected Person | $11,808 per person annually |
| Annual Wellbeing Loss (Beyond Financial) | $326.5 billion in reduced quality of life and premature deaths |
| Combined Economic and Wellbeing Impact | Nearly $400 billion in fiscal year 2018–2019 |
| Productivity Losses (% of total cost) | 75.2% — equating to $48.6 billion in productivity losses annually |
| Healthcare System Costs | $4.6 billion (7.0% of total); individuals pay $363.5 million in out-of-pocket costs |
| Annual Eating Disorder Research Funding | Just 73 cents per person affected — approximately $21 million total |
| Eating Disorder Treatment Received | Only ~6% of people with eating disorders receive any treatment |
| Treatment Cost (Inpatient) | $500–$2,000 per day |
| Treatment Cost (Full Outpatient Recovery) | $100,000–$150,000 per person over a full course of care |
| Global Prevalence Increase (2000–2018) | +124% rise in global eating disorder prevalence |
| COVID-19 Impact | Hospitalizations doubled during the pandemic and have remained elevated through 2024–2025 |
Data Source: National Association of Anorexia Nervosa and Associated Disorders (ANAD); National Eating Disorders Association (NEDA); Deloitte Access Economics — “Social and Economic Cost of Eating Disorders in the United States” (Harvard STRIPED / Academy for Eating Disorders, 2020); JAMA — “Eating Disorders: A Review” (April 2025, Vol. 333, No. 14); ScienceDirect — “A meta-analysis of mortality rates in eating disorders: An update of the literature from 2010 to 2024” (2025); Project HEAL
The headline figure — 10,200 Americans dying every year as a direct result of eating disorders, or one death every 52 minutes — is the kind of statistic that demands to be read twice. For context, that death toll exceeds the number of Americans killed annually by several high-profile public health conditions that receive orders of magnitude more media attention, research funding, and government action. Yet annual research funding for eating disorders amounts to just 73 cents per person affected — a figure that Project HEAL researchers describe as catastrophically inadequate for a condition responsible for this scale of mortality. The standardized mortality ratio of 5.21 for anorexia nervosa — meaning anorexia patients are more than five times more likely to die than age-matched peers — is the highest of any psychiatric condition, yet anorexia remains chronically underfunded in the federal research portfolio.
The economic data from the authoritative Deloitte Access Economics report, commissioned by Harvard’s STRIPED initiative and the Academy for Eating Disorders, crystallizes exactly why these disorders cannot be treated as a niche mental health concern. At $64.7 billion in annual financial costs and a further $326.5 billion in lost wellbeing, eating disorders impose a combined burden of nearly $400 billion per year on the US economy and population — a figure that dwarfs the research and treatment investment by orders of magnitude. The fact that productivity losses alone account for $48.6 billion of this — because the majority of those affected are in their prime working years — means that employers, insurance systems, and government agencies are absorbing the cost of an undertreated crisis while systematically failing to fund the prevention and early intervention that would reduce it.
Eating Disorder Types & Prevalence Statistics in US 2026
| Disorder Type | US Prevalence / Cases | Key Clinical Facts |
|---|---|---|
| Binge Eating Disorder (BED) | Most common eating disorder in the US — affects 2.8 million+ Americans | 1-year prevalence: 1.2% of US adults; more common than anorexia and bulimia combined |
| BED — Females | 1.6% of adult women (lifetime) | 3.5% lifetime prevalence in another estimate |
| BED — Males | 0.8% of adult men (lifetime) | ~40% of BED cases are in men — unusually equal gender split |
| Bulimia Nervosa | Affects approx. 1–3% of women; 0.1–0.5% of men | 1-year prevalence: 0.32% females, 0.05% males |
| Anorexia Nervosa | 0.9% of females (lifetime); 0.3% of males (lifetime) | 1-year prevalence is lower; median age of onset: 12.3 years |
| OSFED (Other Specified Feeding or Eating Disorder) | 39.5% of male eating disorder cases; 44.2% of female cases (US, 2018–19) | Accounts for ~32–35% of all eating disorder cases in clinical settings; 35% of total economic costs |
| ARFID (Avoidant/Restrictive Food Intake Disorder) | Affects 5–14% of children in inpatient eating disorder programs | 13–58% of ARFID patients also have Autism Spectrum Disorder |
| Anorexia Nervosa — Median Age of Onset | 12.3 years old | The risk of death in young people with anorexia is 12 times higher than the general population of the same age |
| Bulimia Nervosa — Median Age of Onset | 18 years old | |
| Binge Eating Disorder — Median Age of Onset | 21 years old | |
| Overall Median Onset Range | 12–13 years old on average | Cases reported in children as young as 6 and adults into their 70s and 80s |
| Children Under 17 — Health Visit Increase | 107.4% rise in eating disorder health visits (2018–2022, US) | 2023 study: 93% increase in eating disorder-related medical visits by youth |
| Diagnoses in Children Under 12 | Increased by 119% over the past two decades | |
| Share of Eating Disorder Patients Attempting Suicide | 31% of anorexia patients; 23% of bulimia and BED patients | BED patients are 4.8 times more likely to attempt suicide than those without an eating disorder |
Data Source: ANAD Eating Disorder Statistics; NEDA Statistics Page; National Institute of Mental Health (NIMH) — Eating Disorders Overview; TherapyRoute Eating Disorders 2025 Statistics; Rehab Seekers 2025–2026 Eating Disorder Prevalence Report; BrightPath Teen Eating Disorder Statistics (2024–2025); JAMA “Eating Disorders: A Review” (April 2025)
Binge Eating Disorder being the most common eating disorder in America is still a fact that catches most people off guard — largely because BED carries the least cultural recognition of any major eating disorder. It affects more than 2.8 million Americans, more than anorexia and bulimia combined, yet it remains one of the most underdiagnosed conditions in US healthcare, in part because patients and providers alike often fail to recognize compulsive overeating as a clinical disorder deserving of formal treatment. The near-equal gender split — with roughly 40% of BED cases occurring in men — makes it one of the few eating disorders where male prevalence approaches female prevalence, yet male patients are still dramatically less likely to be diagnosed because eating disorder screening tools were historically built around female presentation patterns.
The pediatric data is among the most disturbing trend in the entire 2026 eating disorder statistics picture. A 107.4% rise in health visits for eating disorders among children under 17 between 2018 and 2022, and a 93% increase in eating disorder-related medical visits by youth documented in a 2023 study, represent trajectories that experts attribute to the intersection of social media exposure, pandemic-driven anxiety, and social isolation that disrupted normal developmental patterns for an entire generation. With the median age of onset for anorexia at just 12.3 years, and diagnoses now occurring in children as young as 6, the window for early intervention is narrow — and the failure to act swiftly in adolescence dramatically increases the risk of chronic, treatment-resistant illness in adulthood.
Eating Disorder Demographics 2026 | Gender, Age & Population Statistics
| Demographic Group | Key Statistic |
|---|---|
| Females — Lifetime Prevalence | 8.60% overall lifetime prevalence |
| Males — Lifetime Prevalence | 4.07% overall lifetime prevalence |
| Women Estimated to Have Had Eating Disorders (2018–19) | 14.4 million |
| Men Estimated to Have Had Eating Disorders (2018–19) | 6.6 million |
| Share of Eating Disorder Cases That Are Male | 1 in 3 — approximately 10 million men in the US |
| Males Seeking Treatment Increase Since 2021 | +12% more males seeking treatment since 2021 |
| Adolescent Males Diagnosed vs. Females | About 1 in 20 adolescent males vs. females receive a diagnosis |
| Men — Average Delay to Diagnosis vs. Women (BED) | Men wait an average of 18 months longer for a binge eating diagnosis |
| Female Adolescents Prevalence | 3.8% of US female teens have an eating disorder |
| Male Adolescents Prevalence | 1.5% of US male teens have an eating disorder |
| Teens Aged 17–18 | Highest lifetime prevalence for this age group: 3% |
| US Teens (13–18) With Diagnosed Eating Disorder (Annual) | 2.7% each year |
| Women by Age 40s–50s | 15% of women will have an eating disorder by their 40s or 50s; only 27% receive treatment |
| Eating Disorders in Adults 50+ | 41% of women over 50 have current or past core eating disorder symptoms |
| Women Over 50 Currently Trying to Lose Weight | 71.2% — with 79.1% saying weight/shape is a major part of their self-esteem |
| Females Ages 20–29 | 5.79% estimated prevalence — the most affected age-sex group (Statista/WHO data) |
| Girls Beginning to Worry About Weight | As young as age 6–10; by age 14, 60–70% are trying to lose weight |
| Children and Adolescents With Disordered Eating Behaviors (Global) | 22% worldwide show disordered eating behaviors |
| College Students With Eating Disorders (Underweight) | Only 2% of college students meeting eating disorder criteria were classified as “underweight” |
Data Source: ANAD Eating Disorder Statistics (citing Deloitte Access Economics 2020); NEDA Statistics; Statista Eating Disorders in the US (Dec. 2025); Rehab Seekers 2025–2026; BrightPath Teen Eating Disorder Statistics (updated March 2025); JAMA Eating Disorders Review (April 2025); TherapyRoute 2025 Statistics
The gender data on eating disorders in 2026 continues to expose one of the most consequential blind spots in American healthcare. With 1 in 3 eating disorder cases occurring in males — translating to roughly 10 million men — and male diagnostic rates dramatically lagging female rates at every age group, the real prevalence of eating disorders in men is almost certainly being undercounted. When men with binge eating disorder wait an average of 18 months longer for a diagnosis than women presenting with identical symptoms, and when surveys suggest that up to 30% of eating disorder cases may occur in males while screening tools remain calibrated to female presentation patterns, it becomes clear that the 10 million figure is a floor, not a ceiling. The 12% increase in males seeking treatment since 2021 is an encouraging signal but reflects both reduced stigma and the severity of the backlog of unmet need.
The older adult data represents a quieter but equally pressing dimension of the crisis. The finding that 41% of women over 50 have current or previous core eating disorder symptoms — with 13.3% currently active — overturns the prevailing assumption that eating disorders are exclusively a young person’s condition. Women at this life stage face specific triggers including menopause, children leaving home, retirement transitions, and grief that can trigger or worsen disordered eating that often began in adolescence. Yet clinical resources, screening protocols, and public awareness campaigns are almost entirely oriented toward younger patients, leaving older adults largely invisible in the eating disorder support ecosystem. Similarly, the fact that female adolescents aged 20–29 represent the single most affected demographic at a prevalence of 5.79%, while the average age of onset is just 12–13 years, illustrates a decade-long window of untreated suffering for many patients before they reach a statistically peak-prevalence age.
Eating Disorder Statistics by Community 2026 | LGBTQ+, BIPOC & Marginalized Groups
| Community / Group | Key Statistic |
|---|---|
| LGBTQ+ Youth vs. Straight Peers (Overall) | 3 times more likely to have an eating disorder than heterosexual peers |
| Homosexual / Bisexual Girls | 2.5 times higher eating disorder rates than heterosexual girls |
| Homosexual / Bisexual Boys | 6 times higher eating disorder rates than heterosexual boys |
| Gay / Bisexual Men — Binge Eating | 7 times more likely to report binge eating than heterosexual men |
| Gay / Bisexual Men — Purging | 12 times more likely to report purging than heterosexual men |
| Transgender College Students — Eating Disorder Diagnosis | Diagnosed at 4 times the rate of cisgender classmates (NEDA) |
| Transgender College Students — Suicide Attempts | ~75% of transgender college students with eating disorders attempt suicide |
| LGBTQ Youth (13–24) Diagnosed With Eating Disorder | 9% diagnosed; an additional 29% suspect they have one without diagnosis (Trevor Project) |
| Transgender Boys — Eating Disorder Prevalence | 12% diagnosed (highest among LGBTQ+ subgroups, Trevor Project 2021) |
| Non-Binary / Genderqueer LGBTQ+ Youth | 40% reported an eating disorder diagnosis |
| LGBTQ+ Youth With Eating Disorders — Suicide Odds | Nearly 4 times greater odds of attempting suicide in the past year vs. those without ED |
| LGBTQ+ Youth Dissatisfied With Their Body | 87% — nearly nine in ten |
| LGBTQ+ Youth Engaging in Dangerous Weight Control Behaviors | 1 in 3 sexual minority teenagers in the past month |
| Transgender Lifetime Prevalence (Self-Reported) | 10.5% among transgender men; 8.1% among transgender women |
| TGNC Individuals (Transgender / Gender Non-Conforming) | At least 4 times — possibly 8 times — more likely to struggle with an eating disorder |
| BIPOC vs. White Peers — Prevalence | Affected at similar overall rates |
| BIPOC vs. White Peers — Diagnosis Rate | BIPOC individuals are ~half as likely to be diagnosed |
| Black Women vs. White Women — Diagnosis Likelihood | Black women are 25% less likely to be diagnosed with identical eating disorder behaviors |
| BIPOC Patients — Doctor Inquiry Rate | Significantly less likely to be asked about eating disorder symptoms by their doctor |
| Asian American College Students | Report higher body dissatisfaction and more negative attitudes toward obesity than non-Asian BIPOC peers |
| BIPOC / LGBTQ+ Specialized ED Providers (US Total) | Maximum estimated ~150 providers — approximately 5% of the eating disorder provider field |
| Black LGBTQ+ Youth — Gap Between Suspecting and Diagnosed | Suspect they have an eating disorder at 4 times the rate of actually being diagnosed |
Data Source: ANAD Eating Disorder Statistics; NEDA Statistics; The Trevor Project — “Research Brief: Eating Disorders among LGBTQ Youth” (2022); National Alliance for Eating Disorders 2024 Statistics Update; Project HEAL Eating Disorder Statistics; BrightPath Teen Eating Disorder Statistics (2024–2025); Journal of LGBTQ Issues in Counseling (Vol. 18, 2024)
The LGBTQ+ eating disorder data is among the most alarming subgroup findings in the entire US eating disorder landscape, and it reflects a pattern where minority stress — the chronic psychological burden of navigating a society that marginalizes one’s identity — functions as a direct biological and behavioral risk factor for disordered eating. When gay and bisexual men are 12 times more likely to report purging behaviors than their heterosexual peers, and transgender college students are diagnosed with eating disorders at four times the rate of cisgender students, these are not statistical footnotes. They represent the measurable health consequences of body dysphoria, discrimination, and a healthcare system that chronically fails to screen, recognize, or treat eating disorders in gender and sexual minority patients. The finding that 75% of transgender college students with eating disorders attempt suicide should, by any measure, constitute a public health emergency demanding immediate, specialized clinical investment.
The BIPOC treatment gap is equally damning in its specificity. Despite being affected by eating disorders at comparable overall rates to white Americans, Black, Indigenous, and People of Color are half as likely to be diagnosed — a disparity documented not just in patient outcomes but in clinician behavior. When studies show that therapists and doctors presented with identical patient presentations are less likely to identify eating disorder symptoms in Black and Hispanic patients than in white patients, the problem is not patient behavior. It is systemic bias in clinical training, diagnostic tools, and cultural competency. The estimated ~150 BIPOC or LGBTQ+-specialized eating disorder providers in the entire United States — roughly 5% of the provider field — leaves the communities with the most acute unmet need with the fewest culturally competent options. Meanwhile, the annual eating disorder research budget of just $21 million — 73 cents per affected person — ensures this disparity is unlikely to be resolved without a fundamental reallocation of public health priorities.
Eating Disorder Co-Occurring Conditions & Health Consequences 2026
| Comorbidity / Health Consequence | Verified Statistic |
|---|---|
| Anxiety Disorder Comorbidity | 62% of people with a lifetime eating disorder also have an anxiety disorder |
| Mood Disorder Comorbidity | 54% have a comorbid mood disorder |
| PTSD or Substance Use Disorder | 27% have either PTSD or a substance use disorder |
| Depression — Bulimia Nervosa | 76.3% of bulimia patients have lifetime depression (JAMA 2025) |
| Depression — Binge Eating Disorder | 65.5% have lifetime depression (JAMA 2025) |
| Depression — Anorexia Nervosa | 49.5% have lifetime depression (JAMA 2025) |
| PTSD — Residential Treatment Patients | 49.3% of eating disorder patients admitted to US residential facilities show PTSD-compatible symptoms |
| ADHD and Eating Disorders | 6–17% of eating disorder patients also have ADHD |
| Girls With ADHD — Eating Disorder Risk | 3.6 times more likely to have an eating disorder; 5.6 times more likely to have bulimia |
| OCD and Eating Disorders | 10–35% of eating disorder patients have OCD unrelated to the eating disorder |
| Psychiatric Comorbidities (Multiple) | People with eating disorders typically have 1–4 other psychiatric disorders |
| Adolescents With Eating Disorders and Co-Occurring Disorders | Ranging from 55% (anorexia) to 88% (bulimia) have at least one other psychiatric disorder |
| Heart Complications — Anorexia | 20% of anorexia patients develop abnormal heart rhythms; cardiac arrest is the leading cause of death |
| Bone Loss — Anorexia | Up to 90% develop osteopenia or osteoporosis |
| Electrolyte Imbalances | Documented in anorexia and bulimia — includes hyponatremia and hypokalemia (JAMA 2025) |
| Cheek/Face Swelling — Bulimia | 1 in 10 bulimia patients who self-induce vomiting experience painful facial swelling |
| BED and Obesity-Related Conditions | Elevated risk for type 2 diabetes, high blood pressure, and heart disease |
| People With Eating Disorders — Healthcare Costs vs. General Population | 6.3 times higher healthcare costs than the general population |
| Suicide Risk — High Symptom Severity | 11 times more likely to attempt suicide than peers without eating disorders |
| Suicide Risk — Sub-threshold Symptoms | Still 2 times more likely to attempt suicide than the general population |
| Eating Disorder Patients With First-Degree Relative Affected | 7–12 times more likely to develop an eating disorder themselves |
Data Source: ANAD Eating Disorder Statistics; NEDA Statistics; JAMA — “Eating Disorders: A Review” (April 2025, Vol. 333, No. 14); TherapyRoute Eating Disorders 2025 Statistics; ScienceDirect — Meta-analysis of mortality rates (2025); Deloitte Access Economics / Harvard STRIPED Report
The comorbidity data for eating disorders paints a clinical picture of profound complexity — these are rarely standalone conditions. When 62% of eating disorder patients also have an anxiety disorder, 54% have a mood disorder, and individuals with eating disorders typically carry one to four additional psychiatric diagnoses, the clinical challenge shifts from treating a single condition to managing an interconnected web of mental health problems that reinforce each other. The finding that 76.3% of bulimia nervosa patients have a lifetime history of depression — with 65.5% of BED patients and 49.5% of anorexia patients also affected — means that any treatment approach that focuses solely on eating behavior without addressing the co-occurring mood disorder is almost guaranteed to produce poor long-term outcomes. This is not a minor clinical nuance; it is a foundational fact about how eating disorders operate that should shape every screening protocol and treatment plan.
The physical health consequences documented in the 2025 JAMA review and elsewhere are equally severe. The fact that up to 90% of anorexia patients develop osteopenia or osteoporosis — with bone loss during critical developmental years that may never fully reverse — means the health consequences of eating disorders extend decades beyond the active illness phase. Cardiac arrest is the leading cause of death in anorexia, with approximately 20% of patients developing abnormal heart rhythms as starvation progressively weakens the heart muscle and disrupts electrolyte balance. Healthcare costs for people with eating disorders run at 6.3 times the rate of the general population, yet the treatment access statistics tell a story of a system that is spending enormous money managing the acute consequences of a condition it is systematically failing to prevent or treat effectively at the point of initial onset.
Eating Disorder Treatment Statistics US 2026 | Access, Gaps & Recovery Rates
| Treatment / Recovery Metric | Verified Statistic |
|---|---|
| People Receiving Treatment | Only ~6% of people with eating disorders receive any formal treatment |
| Bulimia — Treatment Received | Only 6% of those with bulimia receive treatment |
| Adults With Past-Year Eating Disorder Receiving Treatment | 50.0–63.2% of those with a past-year diagnosis received specific eating disorder treatment |
| Full Recovery Rate (With Treatment) | 60% of patients make a full recovery with treatment |
| Inpatient / Residential Initial Recovery Rate | ~70% initial recovery rate for severe, medically unstable cases |
| Family-Based Treatment (FBT) — Anorexia in Youth | 50–60% success rate; remission at 6–12 months: 48.6% vs. 34.3% with individual therapy (JAMA 2025) |
| CBT + Medication Combined — Remission Rate | 50–70% long-term remission |
| DBT (Dialectical Behavior Therapy) | Helps approximately 60% of patients with co-occurring mood regulation issues |
| Medication — Bingeing Episode Reduction | Reduces bingeing episodes by 20–30% |
| FDA-Approved Medications | Fluoxetine (Prozac) — only FDA-approved drug for bulimia; Vyvanse — approved for moderate-to-severe BED |
| Virtual / Telehealth Outcomes | Comparable to in-person care for 60% of patients with bulimia or BED |
| GLP-1 Medication Trials (Binge Eating) | 2024 trial showed 50% reduction in binge days among weekly GLP-1 recipients |
| Women Seeking Treatment by 40s–50s | 15% develop eating disorders by this age; only 27% receive any treatment |
| Public Insurance vs. Private Insurance — Treatment Access | Youth on public insurance are 1/3 as likely to receive recommended mental health treatment |
| BIPOC Patients — Recommended Treatment Received | Only 40% of BIPOC adolescents suffering malnutrition from eating disorders received recommended treatment |
| Social Media Risk Factor | Teens spending 3+ hours/day on image-focused social media have a 20% higher rate of body dissatisfaction and disordered eating |
| AI / Wearable Technology | AI relapse-prediction tools using wearable data (e.g. heart rate) showing early success in reducing hospital readmissions |
| Annual Eating Disorder Research Funding | $21 million total — 73 cents per person affected |
| NIH Eating Disorder Research Funding vs. Other Conditions | Critically underfunded relative to mortality burden — no federal standard surveillance system exists |
| 1 in 10 Seeking Treatment (NIMH-cited figure) | Only 1 in 10 people with an eating disorder will seek and receive treatment (SingleCare / NIMH) |
Data Source: ANAD Eating Disorder Statistics; NEDA Statistics; Rehab Seekers 2025–2026 Treatment and Prevalence Statistics (citing ANAD, NEDA, SAMHSA 2025 NSDUH); JAMA — “Eating Disorders: A Review” (April 2025); SingleCare Eating Disorder Statistics (updated March 2026); Project HEAL; Deloitte Access Economics / Harvard STRIPED; Brown County Public Health — Eating Disorders Research and Awareness 2025
The treatment access data for eating disorders in 2026 represents one of the widest gaps between need and provision in all of American mental healthcare. When only 6% of people with eating disorders receive any formal treatment — and this is not a misprint — the consequence is that roughly 27 million Americans are navigating one of the deadliest categories of mental illness with no clinical support whatsoever. The barriers are well-documented and multifactorial: cost (with inpatient care running at $500–$2,000 per day and full outpatient recovery costing $100,000–$150,000 per person), insurance gaps across Medicaid, Medicare, and private plans, a shortage of specialized providers, and the pervasive stigma and denial that prevent both patients and their families from recognizing eating disorders as serious medical conditions requiring urgent intervention. For youth on public insurance specifically, the data is particularly stark: they are one-third as likely to receive recommended mental health treatment for their eating disorders as peers with private coverage.
The recovery data, when treatment is actually received, provides a genuinely encouraging counterweight. A 60% full recovery rate with treatment, rising to 70% initial recovery for those receiving residential or inpatient care, demonstrates that eating disorders are treatable — not inevitable life sentences. Family-Based Treatment for adolescent anorexia achieves a remission rate of 48.6% at 6–12 months versus 34.3% with individual therapy — a clinically meaningful difference that JAMA’s 2025 meta-analysis confirms with an odds ratio of 2.08. The emergence of GLP-1 medications showing 50% reduction in binge days in 2024 clinical trials, and AI-assisted relapse prediction tools reducing hospital readmissions in early studies, point toward a new generation of treatment modalities that may significantly expand the therapeutic toolkit. But these advances are largely inaccessible to the 94% of eating disorder patients who currently receive no treatment at all — making improved access, not better treatment science, the defining challenge of US eating disorder statistics in 2026.
Disclaimer: This research report is compiled from publicly available sources. While reasonable efforts have been made to ensure accuracy, no representation or warranty, express or implied, is given as to the completeness or reliability of the information. We accept no liability for any errors, omissions, losses, or damages of any kind arising from the use of this report.

